Please login to the form below

Not currently logged in

AstraZeneca appoints leaders for its Americas business

Makes Rich Fante regional VP, Americas and Marion McCourt chief operating officer of its US business

AstraZeneca had made two leadership appointments to its business in the Americas.

Rich Fante has been appointed regional vice president, Americas, and Marion McCourt takes on the role of chief operating officer for the company's US business.

“Rich is a strong leader who will enable our company to successfully navigate the challenges facing our industry while delivering innovation and value to our customers, patients and shareholders,” said Tony Zook, executive vice president, global commercial operations.

Fante was already responsible for leading AstraZeneca's commercial operations in North America and he will retain his existing responsibilities as president of the company's US business.

Meanwhile, McCourt – currently president and chief executive at AstraZeneca Canada – will be responsible for the day-to-day operation of the US business and heading the US Leadership Team.

“Marion's leadership, vision and extensive experience will help AstraZeneca and the patients we serve well at a critical time for our business in the United States,” Fante said.

23rd November 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...